文献速递骨质疏松与代谢性骨病

尿钙排泄对经骨活检证实骨质疏松患者的肾脏、骨骼和心血管系统的影响:一项纵向长期随访研究

Impact of urinary calcium excretion on kidney, bone, and cardiovascular systems in patients with bone biopsy proven osteoporosis: a longitudinal long-term follow-up study.
PubMed 文献 · Osteoporos Int · 2023-02-15

该纵向研究纳入2008至2015年间在肯塔基大学接受骨活检及24小时尿液采集的230例骨质疏松患者,随访至2021年,平均随访7.2±2.9年。高尿钙不影响肾功能但增加肾结石风险,低尿钙增加心血管疾病风险,尿钙与骨骼健康呈U形关系,维持正常尿钙有益于骨骼健康。

要点

  • 高尿钙不影响eGFR下降速率但预测肾结石发生。
  • 尿钙与骨密度呈U形关系,高尿钙和低尿钙均与骨丢失相关。
  • 低尿钙独立预测主要不良心脏事件和心血管疾病。

核心结论

  • 尿钙排泄与eGFR相关,但不影响eGFR随时间的变化。
  • 尿钙正常的患者上肢骨折发生率更低且骨密度下降更少。
  • 低尿钙排泄预测主要不良心脏事件和心血管疾病。

研究设计与样本

  • 研究为纵向研究,纳入2008年至2015年间在肯塔基大学接受骨活检和24小时尿液采集的所有骨质疏松患者,随访至2021年最后一次就诊。
  • 共纳入230例患者,平均随访7.2±2.9年,平均年龄61岁,基线平均eGFR为85±19 ml/min/1.73 m2。
  • 排除标准为继发性骨质疏松或可能显著影响尿钙排泄的疾病。
  • 单因素分析中有显著意义的结果在包含可能影响患者结局的临床重要协变量的多变量回归模型中得到确认。

主要发现

  • 低骨转换占57%,高骨转换占43%;高尿钙见于三分之一患者,低骨转换与高骨转换组间无差异。
  • 尿钙排泄与eGFR呈正相关,但不影响eGFR随时间下降的速率。
  • 较高的尿钙排泄预测肾结石发生。
  • 高尿钙预测所有部位骨密度丢失,低尿钙也与全髋骨密度更高丢失相关。
  • 上肢骨折是最常见的骨折,其发生率在高尿钙或低尿钙患者中更高。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

UNLABELLED: The impact of urine calcium on kidney, bone, and cardiovascular systems in osteoporosis is not well-known. In this 7-year-follow-up study, high urine calcium did not affect kidney function but increased risk of kidney stones, while low urine calcium increased cardiovascular diseases. Maintaining normal urine calcium is beneficial for bone health. PURPOSE: Hypercalciuria is common in patients with osteoporosis. However, the long-term effect of urinary calcium excretion (UCaE) on patients' health is not well-examined. The current study aims to assess the impact of UCaE on kidney, bone, and cardiovascular outcomes in patients with bone biopsy proven osteoporosis. METHODS: Longitudinal study of all patients with osteoporosis who underwent bone biopsy and 24-h urine collection between 2008 and 2015 in the University of Kentucky. DXA scans, serum markers, kidney function, and cardiovascular events were recorded until last clinic visit in 2021. Exclusion criteria were secondary osteoporosis or conditions that might substantially impact UCaE. The significant results in univariate analysis were confirmed in multi-variable regression models involving clinically important covariates that might impact patients' outcomes. RESULTS: Study included 230 patients with mean follow-up of 7.2 ± 2.9 years. The mean age was 61 years, and the mean eGFR at baseline was 85 ± 19 ml/min/1.73 m2. Low bone turnover (LBT) was present in 57% and high bone turnover (HBT) in 43% of patients. Hypercalciuria was found in one-third of patients with no difference between LTB and HTB. UCaE correlated positively with eGFR but did not affect the rate of eGFR decline over time. Higher UCaE predicted kidney stones development. We observed U-shaped effect of UCaE on bone health. Hypercalciuria predicted loss of BMD at all sites, but also hypocalciuria was associated with higher loss in total hip BMD. Upper limb fractures were the most observed fractures, and their incidence was higher in patients with hyper- or hypo-calciuria. Lower UCaE independently predicted development of major adverse cardiac events (MACE) and cardiovascular disease (CVD). CONCLUSION: UCaE correlated with eGFR but it did not affect the change of eGFR over time. Patients with normal UCaE had lower incidence of upper limb fractures and less reduction in BMD. Low UCaE predicted MACE and CVD.

来源:Osteoporos Int,查看原文。版权归原作者所有。

引用

  1. Abdalbary M, Chishti E, Shakhashiro M, et al. Impact of urinary calcium excretion on kidney, bone, and cardiovascular systems in patients with bone biopsy proven osteoporosis: a longitudinal long-term follow-up study. Osteoporos Int. 2023. PMID: 36790470. doi:10.1007/s00198-023-06686-x

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。